Social media is transforming the patient journey—giving individuals more control over their education, choices, and advocacy. But how can marketers effectively engage in this space while building trust? Underscore Marketing explores how the right social media strategy can empower patients and drive meaningful connections. Read more here: https://lnkd.in/e5xVv47m
The DHC Group
科技、信息和网络
Brooklyn,NY 745 位关注者
The DHC Group is known for cutting edge research, expert strategy, and analytics-driven insights.
关于我们
The DHC Group is known for cutting edge research, expert strategy, and analytics-driven insights. Building on the leadership team’s combined 50+ years of industry experience working with innovative companies, brands, and a wide range of pharmaceutical, biotech, and medical device companies, the DHC Group is designed to provide industry thought leaders and innovative organizations a selective opportunity to define the future of digital health and pharmaceutical marketing. The DHC Group also supports the Digital Health Coalition, a 501c3 non-profit, and its mission of educating pharma marketers to enhance innovation of digital health marketing.
- 网站
-
https://www.thedhcgroup.com
The DHC Group的外部链接
- 所属行业
- 科技、信息和网络
- 规模
- 2-10 人
- 总部
- Brooklyn,NY
- 类型
- 私人持股
地点
-
主要
US,NY,Brooklyn
The DHC Group员工
动态
-
Almost At Capacity - If you work for a pharma company, are local to the Philadelphia area and want to connect next Monday with peers about how the direct to patient trends are evolving, reserve a seat now! ?? https://lnkd.in/esCcs924 Thought leaders Alex Davis (Organon), Chad Maeder (Otsuka Precision Health), Shawna Moore (Novo Nordisk), Chris Moose (Wheel), Lyndi M Hirsch (GoodRx), Aaron Uydess (EVERSANA), Robert Johnstone (GSK), and Amy Turnquist as moderator will explore how data, technology, and virtual care are shaping patient education, access, and support.
-
-
Striking the right balance between audience quality and media efficiency is no easy task—but PulsePoint and Dentsu health made it happen. By refining their approach for a Parkinson’s disease brand, they improved audience quality, reduced media costs, and increased meaningful engagements at key consumer touchpoints. See how they did it and what it means for smarter, more effective healthcare marketing. Read the full case study here: https://lnkd.in/exEThwgB
-
Unlock the latest healthcare insights with ixlayer's new whitepaper! Explore key trends shaping diagnostic testing, patient engagement, and digital health in 2025. This report dives into the future of accessible, personalized care—and what it means for the industry. Get the full whitepaper here: https://lnkd.in/ex2mmB5Z
-
RFK Jr.’s leadership at HHS could bring major changes to pharma marketing—from DTC advertising regulations to drug pricing and preventive health initiatives. PurpleLab’s Theodore Sweetser & MiQ’s Lauren Kushner break down what’s ahead and what it means for your strategy. Read the full analysis here: https://lnkd.in/e9H6BNCz
-
Big conversations are happening around the future of Direct-to-Patient (DTP). On March 17 in Philadelphia, PA, industry leaders Alex Davis (Organon), Chad Maeder (Otsuka Precision Health), Shawna Moore (Novo Nordisk), Chris Moose (Wheel), Lyndi M Hirsch (GoodRx), Aaron Uydess (EVERSANA), Robert Johnstone (GSK), and Amy Turnquist as moderator will gather for an invite-only, in-person roundtable to explore how data, technology, and virtual care are shaping patient education, access, and support. Space is limited! If you are a pharmaceutical marketer and would like to be considered for attendance, submit your invitation request here: https://lnkd.in/esCcs924
-
Could restricting pharmaceutical TV ads actually do more harm than good? M3 MI explores this question, diving into insights from the MARS Consumer Health Study. While some argue that a ban could lead to more cautious prescribing, the data suggests that exposure to healthcare advertising helps patients feel more informed, build trust with brands, and take a more active role in their care. Read the full analysis here: https://lnkd.in/eUAbVBSK
-
Systemic challenges continue to create barriers in patient services, but innovative models like Direct-to-Patient (DTP) are transforming how care is delivered. In this article from EVERSANA, discover how new approaches are reshaping patient support and improving access. Read the full article here: https://lnkd.in/eTYBF2k4
-
?? Happening TODAY at 1 PM ET! ?? Don’t miss our "Reimagining Patient Acquisition" webinar featuring Xander Kerman Gregory (Ubie) and Halle Marchese (Nucleus Genomics) as they share groundbreaking strategies that are reshaping how brands connect with patients. Join us to explore: ??How Nucleus Genomics leverages communities, influencers, and events for patient acquisition ??How Ubie is redefining engagement by reaching patients earlier with innovative channels ??Actionable takeaways to refine your pharma marketing strategy It’s not too late to register and join us LIVE! ?? Today, March 6 | 1 PM ET ?? Register now: https://lnkd.in/euuigkdm
-
-
DHCG Exclusive Roundtable: The State of Direct-to-Patient in Pharma Join us on March 17 in Philadelphia, PA for an invite-only, in-person roundtable where industry leaders Alex Davis (Organon), Chad Maeder (Otsuka Precision Health), Shawna Moore (Novo Nordisk), Chris Moose (Wheel), Lyndi M Hirsch (GoodRx), Aaron Uydess (EVERSANA), Robert Johnstone (GSK), and Amy Turnquist as moderator will explore how data, technology, and virtual care are shaping patient education, access, and support. ?? Be the first to access our latest DTP Trends Research. ?? Engage in thought-provoking discussions on treatment awareness, insurance navigation, prescription fulfillment, and more! Space is limited! If you are a pharmaceutical marketer and would like to be considered for attendance, submit your invitation request here: https://lnkd.in/esCcs924
-